Shareholding disclosure
Santhera Pharmaceuticals Holding AG
Declared position
91.7%
Threshold
Crossed downwards
Timeline
Published
11.05.2021
Transaction
04.05.2021
Voting rights breakdown
Voting rights acquired8.82%
Voting rights sold91.7%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAL5A00099
Beneficial owner
Santhera Pharmaceuticals Holding AG
Declared address
Santhera Pharmaceuticals Holding AG, Pratteln
Also regarding certain sales positions.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open